Literature DB >> 18716932

Pattern recognition at the maternal-fetal interface.

Vikki M Abrahams1.   

Abstract

Intrauterine infections represent a significant threat to fetal well-being and pregnancy outcome. Recent studies suggest that non-immune cells of the maternal-fetal interface can actively recognize and respond to microbes through pattern recognition receptors, in order to control pathogens that may compromise the pregnancy. However, these same innate immune responses may inadvertently lead to excessive inflammation or apoptosis at the maternal-fetal interface. Thus, pattern recognition receptors may play a key role in infection-related pregnancy complications. This review discusses what is currently known about the role of Toll-like receptors and NOD-like receptors in controlling infections at the maternal-fetal interface, and what impact their function may have on pregnancy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716932     DOI: 10.1080/08820130802191599

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  31 in total

1.  Viral ssRNA induces first trimester trophoblast apoptosis through an inflammatory mechanism.

Authors:  Paulomi B Aldo; Melissa J Mulla; Roberto Romero; Gil Mor; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2010-02-17       Impact factor: 3.886

2.  Trophoblast-secreted soluble-PD-L1 modulates macrophage polarization and function.

Authors:  Yong-Hong Zhang; Paulomi Aldo; Yuan You; Jiahui Ding; Janina Kaislasuo; Jesper F Petersen; Ellen Lokkegaard; Gang Peng; Michael J Paidas; Samantha Simpson; Lubna Pal; Seth Guller; Hong Liu; Ai Hua Liao; Gil Mor
Journal:  J Leukoc Biol       Date:  2020-05-09       Impact factor: 4.962

3.  Placental TNF-α signaling in illness-induced complications of pregnancy.

Authors:  Pamela A Carpentier; Andra L Dingman; Theo D Palmer
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

4.  Uric acid induces trophoblast IL-1β production via the inflammasome: implications for the pathogenesis of preeclampsia.

Authors:  Melissa J Mulla; Kledia Myrtolli; Julie Potter; Crina Boeras; Paula B Kavathas; Anna K Sfakianaki; Serkelem Tadesse; Errol R Norwitz; Seth Guller; Vikki M Abrahams
Journal:  Am J Reprod Immunol       Date:  2011-06       Impact factor: 3.886

5.  Viral infection dampens human fetal membrane type I interferon responses triggered by bacterial LPS.

Authors:  Julie A Potter; Mancy Tong; Paulomi Aldo; Ja Young Kwon; Mary Pitruzzello; Gil Mor; Vikki M Abrahams
Journal:  J Reprod Immunol       Date:  2020-04-08       Impact factor: 4.054

Review 6.  Molecular Regulation of Parturition: The Role of the Decidual Clock.

Authors:  Errol R Norwitz; Elizabeth A Bonney; Victoria V Snegovskikh; Michelle A Williams; Mark Phillippe; Joong Shin Park; Vikki M Abrahams
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-27       Impact factor: 6.915

7.  Human amnion mesenchymal cells are pro-inflammatory when activated by the Toll-like receptor 2/6 ligand, macrophage-activating lipoprotein-2.

Authors:  Brittany L Sato; Eric S Collier; Sheryl Anne Vermudez; Anthony D Junker; Claire E Kendal-Wright
Journal:  Placenta       Date:  2016-06-11       Impact factor: 3.481

8.  Bacterial modulation of human fetal membrane Toll-like receptor expression.

Authors:  Vikki M Abrahams; Julie A Potter; Geeta Bhat; Morgan R Peltier; George Saade; Ramkumar Menon
Journal:  Am J Reprod Immunol       Date:  2012-09-11       Impact factor: 3.886

9.  Human fetal membranes generate distinct cytokine profiles in response to bacterial Toll-like receptor and nod-like receptor agonists.

Authors:  Mai Hoang; Julie A Potter; Stefan M Gysler; Christina S Han; Seth Guller; Errol R Norwitz; Vikki M Abrahams
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

10.  Single- and double-stranded viral RNA generate distinct cytokine and antiviral responses in human fetal membranes.

Authors:  S L Bakaysa; J A Potter; M Hoang; C S Han; S Guller; E R Norwitz; V M Abrahams
Journal:  Mol Hum Reprod       Date:  2014-04-09       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.